News
Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...
1d
Clinical Trials Arena on MSNAstellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trialAstellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...
Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...
New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...
7d
News-Medical.Net on MSNGenomic study of non-Hispanic Black veterans with prostate cancer yields key insights for precision medicineIn the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...
HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking health news and prostate cancer awareness ...
Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...
Prostate cancer survivor Al Roker offered some words of support after former President Joe Biden publicly revealed he was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results